OCUL
Ocular Therapeutix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.64
+0.00%0
Insider buys (3m)
5
Insider sells (3m)
-$333.1K
Net value (3m)
+29.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Notman Donald · officer: Chief Operating Officer | Sale | 1,099 | $10 |
| Aug 26, 2026 | Heier Jeffrey S. · officer: Chief Scientific Officer | Sale | 3,296 | $11 |
| Aug 26, 2026 | Kaiser Peter · officer: Chief Development Officer | Sale | 3,035 | $11 |
| Aug 26, 2026 | Dugel Pravin · director, officer: See Remarks | Sale | 21,649 | $11 |
| Aug 26, 2026 | Nayak Sanjay · officer: Chief Strategy Officer | Sale | 1,897 | $11 |
| Jun 12, 2026 | Robins Jason Shand · officer: Chief Financial Officer | A-Award | 14,024 | $8.74 |
| Jun 12, 2026 | Warden Charles M · director | A-Award | 44,000 | $8.74 |
| Jun 12, 2026 | Hong Seung Suh · director | A-Award | 44,000 | $8.74 |
| Jun 12, 2026 | Warden Charles M · director | A-Award | 14,000 | $0.00 |
| Jun 12, 2026 | LINDSTROM RICHARD L MD · director | A-Award | 14,000 | $0.00 |
| Jun 12, 2026 | Williams Leslie J. · director | A-Award | 14,000 | $0.00 |
| Jun 12, 2026 | Graves Adrienne L · director | A-Award | 44,000 | $8.74 |
| Jun 12, 2026 | Hong Seung Suh · director | A-Award | 14,000 | $0.00 |
| Jun 12, 2026 | Williams Leslie J. · director | A-Award | 44,000 | $8.74 |
| Jun 12, 2026 | LINDSTROM RICHARD L MD · director | A-Award | 44,000 | $8.74 |
| Jun 12, 2026 | RAINES MERILEE · director | A-Award | 44,000 | $8.74 |
| Jun 12, 2026 | Graves Adrienne L · director | A-Award | 14,000 | $0.00 |
| Jun 12, 2026 | RAINES MERILEE · director | A-Award | 14,000 | $0.00 |
| Jun 12, 2026 | Robins Jason Shand · officer: Chief Financial Officer | A-Award | 15,441 | $0.00 |
| Jun 5, 2026 | Waheed Nadia · officer: Chief Medical Officer | Sale | 14,828 | $8.27 |
| May 28, 2026 | Nayak Sanjay · officer: Chief Strategy Officer | Sale | 1,858 | $8.20 |
| May 28, 2026 | Dugel Pravin · director, officer: See Remarks | Sale | 21,156 | $8.20 |
| May 28, 2026 | Heier Jeffrey S. · officer: Chief Scientific Officer | Sale | 3,018 | $8.20 |
| May 28, 2026 | Kaiser Peter · officer: Chief Development Officer | Sale | 2,967 | $8.20 |
| Feb 25, 2026 | Nayak Sanjay · officer: Chief Strategy Officer | Sale | 1,759 | $8.28 |
| Feb 25, 2026 | Dugel Pravin · director, officer: See Remarks | Sale | 20,056 | $8.28 |
| Feb 25, 2026 | Kaiser Peter · officer: Chief Development Officer | Sale | 2,810 | $8.28 |
| Feb 25, 2026 | Heier Jeffrey S. · officer: Chief Scientific Officer | Sale | 3,057 | $8.28 |
| Feb 24, 2026 | LINDSTROM RICHARD L MD · director | Purchase | 60,229 | $7.66 |
| Feb 24, 2026 | Waheed Nadia · officer: Chief Medical Officer | Sale | 3,510 | $7.74 |
Institutional positioning
13F filings over the trailing two quarters
New 111Increased 211Reduced 148Sold out 40
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 32,844,043 | Aug 13, 2026 |
| FMR LLC | Increased | 32,653,764 | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 19,686,282 | May 15, 2026 |
| Deep Track Capital, LP | Unchanged | 19,686,282 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 19,376,555 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 16,132,931 | May 13, 2026 |
| Avoro Capital Advisors LLC | Increased | 12,540,000 | Aug 14, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 12,315,000 | May 15, 2026 |
| SUMMER ROAD LLC | Increased | 12,208,296 | Aug 10, 2026 |
| SUMMER ROAD LLC | Increased | 11,879,825 | Apr 23, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 10,777,777 | Mar 16, 2026 |
| VR Adviser, LLC | Unchanged | 10,346,926 | Aug 14, 2026 |
| VR ADVISER, LLC | Increased | 10,346,926 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 8,832,595 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 8,719,039 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026